At LuMind IDSC Foundation, we accelerate research to increase availability of therapeutic, diagnostic, and medical care options and we empower families through education, connections, and support.
LIFE-DSR - A National Launch for the Natural History Study in Adults with Down Syndrome


May 30, 2019 04:00 PM

LuMind IDSC logo
* Required information


James Hendrix, Ph.D.
Chief Scientific Officer @LuMind IDSC Foundation
Prior to joining LuMind, Dr. Hendrix was director, global science initiatives, at the Alzheimer’s Association. As a member of the Medical and Scientific Relations Division, he provided leadership on specific domestic and international efforts focused on advancing the division’s science agenda. A critical element of his role is to manage industry consortia such as the Alzheimer’s Association Research Roundtable (AARR); lead the Global Biomarker Standardization Consortium; manage and direct future meeting efforts and output; and assist with the coordination of the $100 million dollar Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study on the clinical usefulness of amyloid PET imaging. Before joining the Alzheimer’s Association, Dr. Hendrix was a pharmaceutical scientist with a focus on drug discovery for CNS diseases. Dr. Hendrix spent 18 years working at Sanofi-Aventis and predecessor companies, where he rose to level of senior director, U.S. site head for CNS research.